![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Artivion Reports Second Quarter 2024 Financial Results PR Newswire ATLANTA, Aug. 8, 2024 Second Quarter Highlights: Achieved revenue of $98.0 million in the second quarter of 2024 versus $89.3...
Artivion to Participate in Upcoming Investor Conferences PR Newswire ATLANTA, Aug. 5, 2024 ATLANTA, Aug. 5, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular...
Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2024 Financial Results PR Newswire ATLANTA, July 25, 2024 ATLANTA, July 25, 2024 /PRNewswire/ -- Artivion, Inc...
Artivion Amends Agreements with Endospan PR Newswire ATLANTA, July 1, 2024 Provides Endospan with $25 million of Additional Debt Funding to Obtain FDA Approval for NEXUS Upfront Payment...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 100.6 | 105.05 | 50.2 | 90 | 81.93254973 | DE |
260 | 0 | 0 | 101 | 108.5 | 50.2 | 134 | 92.38741188 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions